#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer
Click to read this study in JAMA Network Open.
Tag: Selective estrogen receptor modulators
#VisualAbstract: Concurrent use of tamoxifen with direct oral anticoagulants is not associated with an increased risk of hemorrhage
Click to read this study in JAMA Network Open.
#VisualAbstract: Fulvestrant-palbociclib and letrozole-palbociclib are equally effective for HR⁺ advanced breast cancer
Click here to read this study in JAMA Oncology.
#VisualAbstract: Addition of everolimus to letrozole improves survival in patients with HR⁺ breast cancer and disease progression on tamoxifen
Click to read this study in JAMA Oncology.
#VisualAbstract: Early discontinuation of endocrine therapy may increase risk of breast cancer recurrence in premenopausal women
Click to read the study in Clinical Cancer Research.
USPSTF recommends use of risk-reducing medications for breast cancer
Image: PD 1. Based on a review of recent evidence, the U.S.Preventive Service Task Force (USPSTF) has released a statement ...
Selective estrogen receptor modulators reduce breast cancer risk even after treatment
Image: PD 1. Selective estrogen receptor modulators (SERMs) reduce the risk of ER-positive invasive breast cancer in high-risk women for ...
Get the app